Impact of Screens on Children's Growth
NCT07026812 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2025-06-18
Summary
Short stature is defined as a height less than -2 Standard Deviations (SD) for age and a slowing of growth velocity by a loss of 1 SD/year. The causes of short stature are multiple (chronic diseases, growth hormone deficiency, hypothyroidism, hyperadrenocorticism, genetic syndromes, etc.). However, nearly 30% are considered idiopathic, with no identified etiology (Naccache et al., unpublished).
Growth hormone (GH) is secreted in a pulsatile manner with maximum peaks primarily at night, raising questions about the relationship between sleep disturbances and short stature.
In children, one of the main causes of sleep disturbances in the digital age is screen use, which is becoming increasingly important, particularly in the pediatric population.
Conditions
- Growth Disorders
Sponsors & Collaborators
-
University Hospital, Rouen
lead OTHER
Principal Investigators
-
Mireille MC CASTANET, Professor · University Hospital, Rouen
-
Mireille MC CASTANET, Professor · University Hospital, Rouen
Eligibility
- Min Age
- 6 Years
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-26
- Primary Completion
- 2024-09-11
- Completion
- 2025-06-01
Countries
- France
Study Locations
More Related Trials
-
Growth Hormone and Endothelial Function in Children
NCT00373386 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess Growth in Children With Idiopathic Short Stature
NCT06309979 ·Status: RECRUITING
-
Evolution of the Quality of Life of Short Statured Children Treated With Growth Hormone : Evaluation at Adult Size
NCT05195437 ·Status: COMPLETED
-
A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
NCT05894876 ·Status: TERMINATED
-
Severe Decrease of Growth Velocity in Children With Anorexia Nervosa.Therapeutic Trial of Growth Hormone
NCT01626833 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height
NCT00174421 ·Status: COMPLETED ·Phase: PHASE3
-
Retrospective Study Of The Influence Of Age At Start Of Growth Hormone Treatment On Height Gain In Children Born Small for Gestational Age
NCT01897753 ·Status: COMPLETED
-
Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing
NCT01110928 ·Status: COMPLETED
-
Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia.
NCT03794609 ·Status: TERMINATED
-
A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height
NCT00840944 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age
NCT00174408 ·Status: COMPLETED ·Phase: PHASE3
-
Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short Stature
NCT00355030 ·Status: COMPLETED ·Phase: PHASE3
-
Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm
NCT00163189 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height
NCT00396474 ·Status: WITHDRAWN
-
A Study in Children With Achondroplasia
NCT07301463 ·Status: RECRUITING
-
The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature
NCT01970800 ·Status: WITHDRAWN ·Phase: NA
-
Elucidation of the Effects of Growth Hormone (GH) Deficiency and GH Replacement on Clot and Platelet
NCT02049671 ·Status: UNKNOWN
-
Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation
NCT01734447 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children
NCT06103513 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of Exogenous Growth Hormone on Ocular Findings
NCT05338411 ·Status: UNKNOWN
-
Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children
NCT00438217 ·Status: UNKNOWN ·Phase: PHASE4
-
Growth Hormone Therapy in Osteogenesis Imperfecta
NCT00001305 ·Status: COMPLETED ·Phase: PHASE3
-
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
NCT00396097 ·Status: COMPLETED ·Phase: PHASE3
-
Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF)
NCT01438801 ·Status: WITHDRAWN ·Phase: PHASE4
-
Growth Hormone (GH) in Congenital Adrenal Hyperplasia
NCT03162172 ·Status: COMPLETED